Report Detail
Global (United States, European Union and China) Tissue Plasminogen Activator Market Research Report 2019-2025
- RnM3682876 |
- 19 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Tissue plasminogen activator (abbreviated tPA or PLAT) is a protein involved in the breakdown of blood clots. It is a serine protease found on endothelial cells, the cells that line the blood vessels. As an enzyme, it catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for clot breakdown. Human tPA has a molecular weight of ~70 kDa in the single-chain form.
In 2019, the market size of Tissue Plasminogen Activator is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tissue Plasminogen Activator.
This report studies the global market size of Tissue Plasminogen Activator, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Tissue Plasminogen Activator sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bayer AG
Genentech
Sigma-Aldrich
Taj Pharmaceuticals
Zydus Cadila Healthcare
Calbiochem
...
Market Segment by Product Type
Active tPA
tPA Complexed with Inhibitor Type 1 (PAI-1)
tPA Complexed with C1-inhibitor
Market Segment by Application
Ischemic Stroke
Pulmonary Embolism
Myocardial Infarction
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Tissue Plasminogen Activator status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Tissue Plasminogen Activator manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Tissue Plasminogen Activator are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Tissue Plasminogen Activator Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Active tPA
- 1.3.3 tPA Complexed with Inhibitor Type 1 (PAI-1)
- 1.3.4 tPA Complexed with C1-inhibitor
- 1.4 Market Segment by Application
- 1.4.1 Global Tissue Plasminogen Activator Market Share by Application (2019-2025)
- 1.4.2 Ischemic Stroke
- 1.4.3 Pulmonary Embolism
- 1.4.4 Myocardial Infarction
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Tissue Plasminogen Activator Market Size
- 2.1.1 Global Tissue Plasminogen Activator Revenue 2014-2025
- 2.1.2 Global Tissue Plasminogen Activator Sales 2014-2025
- 2.2 Tissue Plasminogen Activator Growth Rate by Regions
- 2.2.1 Global Tissue Plasminogen Activator Sales by Regions 2014-2019
- 2.2.2 Global Tissue Plasminogen Activator Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Tissue Plasminogen Activator Sales by Manufacturers
- 3.1.1 Tissue Plasminogen Activator Sales by Manufacturers 2014-2019
- 3.1.2 Tissue Plasminogen Activator Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Tissue Plasminogen Activator Revenue by Manufacturers (2014-2019)
- 3.2.2 Tissue Plasminogen Activator Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Tissue Plasminogen Activator Market Concentration Ratio (CR5 and HHI)
- 3.3 Tissue Plasminogen Activator Price by Manufacturers
- 3.4 Key Manufacturers Tissue Plasminogen Activator Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Tissue Plasminogen Activator Market
- 3.6 Key Manufacturers Tissue Plasminogen Activator Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Active tPA Sales and Revenue (2014-2019)
- 4.1.2 tPA Complexed with Inhibitor Type 1 (PAI-1) Sales and Revenue (2014-2019)
- 4.1.3 tPA Complexed with C1-inhibitor Sales and Revenue (2014-2019)
- 4.2 Global Tissue Plasminogen Activator Sales Market Share by Type
- 4.3 Global Tissue Plasminogen Activator Revenue Market Share by Type
- 4.4 Tissue Plasminogen Activator Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Tissue Plasminogen Activator Sales by Application
6 United States
- 6.1 United States Tissue Plasminogen Activator Breakdown Data by Company
- 6.2 United States Tissue Plasminogen Activator Breakdown Data by Type
- 6.3 United States Tissue Plasminogen Activator Breakdown Data by Application
7 European Union
- 7.1 European Union Tissue Plasminogen Activator Breakdown Data by Company
- 7.2 European Union Tissue Plasminogen Activator Breakdown Data by Type
- 7.3 European Union Tissue Plasminogen Activator Breakdown Data by Application
8 China
- 8.1 China Tissue Plasminogen Activator Breakdown Data by Company
- 8.2 China Tissue Plasminogen Activator Breakdown Data by Type
- 8.3 China Tissue Plasminogen Activator Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Tissue Plasminogen Activator Breakdown Data by Company
- 9.2 Rest of World Tissue Plasminogen Activator Breakdown Data by Type
- 9.3 Rest of World Tissue Plasminogen Activator Breakdown Data by Application
- 9.4 Rest of World Tissue Plasminogen Activator Breakdown Data by Countries
- 9.4.1 Rest of World Tissue Plasminogen Activator Sales by Countries
- 9.4.2 Rest of World Tissue Plasminogen Activator Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Bayer AG
- 10.1.1 Bayer AG Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Tissue Plasminogen Activator
- 10.1.4 Tissue Plasminogen Activator Product Introduction
- 10.1.5 Bayer AG Recent Development
- 10.2 Genentech
- 10.2.1 Genentech Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Tissue Plasminogen Activator
- 10.2.4 Tissue Plasminogen Activator Product Introduction
- 10.2.5 Genentech Recent Development
- 10.3 Sigma-Aldrich
- 10.3.1 Sigma-Aldrich Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Tissue Plasminogen Activator
- 10.3.4 Tissue Plasminogen Activator Product Introduction
- 10.3.5 Sigma-Aldrich Recent Development
- 10.4 Taj Pharmaceuticals
- 10.4.1 Taj Pharmaceuticals Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Tissue Plasminogen Activator
- 10.4.4 Tissue Plasminogen Activator Product Introduction
- 10.4.5 Taj Pharmaceuticals Recent Development
- 10.5 Zydus Cadila Healthcare
- 10.5.1 Zydus Cadila Healthcare Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Tissue Plasminogen Activator
- 10.5.4 Tissue Plasminogen Activator Product Introduction
- 10.5.5 Zydus Cadila Healthcare Recent Development
- 10.6 Calbiochem
- 10.6.1 Calbiochem Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Tissue Plasminogen Activator
- 10.6.4 Tissue Plasminogen Activator Product Introduction
- 10.6.5 Calbiochem Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Tissue Plasminogen Activator Sales Channels
- 11.2.2 Tissue Plasminogen Activator Distributors
- 11.3 Tissue Plasminogen Activator Customers
12 Market Forecast
- 12.1 Global Tissue Plasminogen Activator Sales and Revenue Forecast 2019-2025
- 12.2 Global Tissue Plasminogen Activator Sales Forecast by Type
- 12.3 Global Tissue Plasminogen Activator Sales Forecast by Application
- 12.4 Tissue Plasminogen Activator Forecast by Regions
- 12.4.1 Global Tissue Plasminogen Activator Sales Forecast by Regions 2019-2025
- 12.4.2 Global Tissue Plasminogen Activator Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Tissue Plasminogen Activator. Industry analysis & Market Report on Tissue Plasminogen Activator is a syndicated market report, published as Global (United States, European Union and China) Tissue Plasminogen Activator Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Tissue Plasminogen Activator market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
